-
Higher Pretreatment HER2 Amplicon mRNA Signature Predicts Improved Outcomes With Trastuzumab Deruxtecan in Metastatic Breast Cancer
03 Jun 2025 00:14 GMT
… with HER2-negative metastatic breast cancer who have a … with T-DXd for [metastatic breast cancer],” Paolo Tarantino, MD, … retrieved from patients with metastatic breast cancer at Dana-Farber … having HER2-positive metastatic breast cancer and 16 having HER2 …
-
2025 ASCO Presentation: Innovent Biologics Announces Updated Data of IBI354 (Novel anti-HER2 ADC) From the Phase 1/2 Clinical Study in Advanced Ovarian Cancer, Breast Cancer and Other Solid Tumors
03 Jun 2025 02:00 GMT
… as ovarian cancer and breast cancer, but also validates … and metastasis of breast cancer, with approximately 15%-20% of breast cancer patients … in the field of breast cancer treatment.”
Dr. Hui … targeted therapies and in metastatic tumors. Innovent Biologics …
-
Understanding the Side Effects of RLY-2608 in HR+, HER2– Breast Cancer
03 Jun 2025 01:39 GMT
… (HR)-positive, HER2-negative advanced breast cancer during the ReDiscover trial, according … the associate director of the Metastatic Breast Cancer Program. She also serves as …
-
Dr Tolaney on the PFS Benefit With First-Line T-DXd Plus Pertuzumab in HER2+ Breast Cancer
03 Jun 2025 00:13 GMT
… with HER2-positive advanced/metastatic breast cancer.
-
Breast Cancer Targeted Therapies and Guidelines, Part 2
03 Jun 2025 00:55 GMT
… possible in breast cancer treatment.
Breast Cancer Targeted … adhesion, invasion, and metastasis. SRC itself is … breast cancer, especially in HR-positive breast cancer and HER2-positive breast cancer … For HER2-positive breast cancers, adjuvant trastuzumab …
-
STAT+: Enhertu, used as first option, stalled tumors for more than a year in women with breast cancer, study finds
02 Jun 2025 22:25 GMT
… with a type of metastatic but previously untreated breast cancer — study results … used to treat HER2-positive breast cancer can now be measured in … HER2-positive metastatic breast cancer,” said Rebecca Dent, an oncologist and breast cancer specialist at …
-
Understanding Cancer Changes and Testing: How Testing Guides Your Metastatic Breast Cancer Treatment
02 Jun 2025 16:50 GMT
-
Cardiff Oncology Announces Positive Data from Investigator-Initiated Trial of Onvansertib in Combination with Paclitaxel in Metastatic Triple-Negative Breast Cancer Presented at ASCO 2025
02 Jun 2025 20:05 GMT
… paclitaxel for metastatic triple negative breast cancer demonstrated 40% … patients with metastatic triple-negative breast cancer (mTNBC) … . “Triple-negative breast cancer is among the … Paclitaxel in Metastatic Triple-Negative Breast Cancer Patients (mTNBC …
-
Trastuzumab Deruxtecan Plus Pertuzumab Improves PFS vs Standard Care in HER2+ Breast Cancer
02 Jun 2025 18:50 GMT
… of HER2-positive metastatic breast cancer that is both … positive (HER2+) advanced/metastatic breast cancer (a/mBC): … docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of- … plus docetaxel for metastatic breast cancer. N Engl J Med …
-
Initial Enhertu Combo Improves Survival in HER2+ Advanced Breast Cancer
02 Jun 2025 18:41 GMT
… with HER2-positive advanced or metastatic breast cancer, according to findings from … with HER2-positive metastatic or advanced breast cancer were randomly assigned 1 … pathologically documented advanced or metastatic HER2-positive breast cancer, and no prior …
About
© 1995-2025